Global Bovine Ephemeral Fever Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Bovine Ephemeral Fever Vaccines Market is presumed to reach the market size of nearly USD 93.02 MN by 2030 from USD 72.35 MN in 2022 with a CAGR of 3.19% under the study period 2023 - 2030.

Bovine ephemeral fever (BEF), also commonly referred to as three-day sickness, is a viral illness that impacts cattle and water buffalo. BEF vaccines are vaccines developed to prevent or control this disease.

MARKET DYNAMICS:

Regions with a history of bovine ephemeral fever outbreaks and areas where the disease is endemic rely on these vaccines to protect cattle and water buffalo herds. The economic impact of this disease, including reduced milk production and weight loss, drives demand as farmers seek to safeguard their livestock and maintain productivity. Government initiatives often involve vaccination programs to control and prevent bovine ephemeral fever outbreaks, further promoting vaccine use. The globalization of livestock trade has expanded the market, reaching regions previously unaffected by the disease. Ongoing research and development efforts enhance vaccine formulations and delivery methods, making them more attractive to producers and users. Increasing awareness, education campaigns, and regulatory approvals further support vaccination practices. Environmental factors and insect vector control also impact bovine ephemeral fever outbreaks, potentially increasing the need for vaccines. The bovine ephemeral fever vaccine market continues to evolve with advancements in research, technology, and changing disease dynamics, ensuring its relevance in protecting cattle and water buffalo populations globally.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bovine ephemeral fever vaccines. The growth and trends of bovine ephemeral fever vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the bovine ephemeral fever vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Live Vaccine
Killed Vaccine
Others

By Application

Cattle
Water Buffaloes

By End-User

Medical Device Companies
Pharmaceutical Industries
Animal Hospitals
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Bovine Ephemeral Fever Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bovine Ephemeral Fever Vaccines market include Zoetis Inc, Onderstepoort Biological Products SOC Ltd, Green Cross Veterinary Products Co Ltd, Veterinary Serum & Vaccine Research Institute and CAVAC (ChoongAng Vaccine Laboratories Co Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112314

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BOVINE EPHEMERAL FEVER VACCINES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Live Vaccine Historic and Forecast Sales by Regions
5.5 Killed Vaccine Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Cattle Historic and Forecast Sales by Regions
6.5 Water Buffaloes Historic and Forecast Sales by Regions

7 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Medical Device Companies Historic and Forecast Sales by Regions
7.5 Pharmaceutical Industries Historic and Forecast Sales by Regions
7.6 Animal hospitals Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BOVINE EPHEMERAL FEVER VACCINES COMPANIES

9.1. Bovine Ephemeral Fever Vaccines Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BOVINE EPHEMERAL FEVER VACCINES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Zoetis Inc
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Onderstepoort Biological Products SOC Ltd
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Green Cross Veterinary Products Co Ltd
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Veterinary Serum & Vaccine Research Institute
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. CAVAC ChoongAng Vaccine Laboratories Co Ltd
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies